22 results
8-K
EX-99.2
STSA
Satsuma Pharmaceuticals Inc
20 Dec 22
Satsuma Pharmaceuticals Provides STS101 Development Program and Corporate Update
4:19pm
Commercial supply chain and commercial-scale manufacturing capability established Formulation manufacture by world-class CMO Manufacture of nasal delivery
S-3
ytoo9bg50u7t
23 Oct 20
Shelf registration
4:48pm
10-K
zs0n7sd09h
10 Mar 20
Annual report
4:20pm
10-Q
zfvovus0cfip 1cablxp
12 Nov 19
Quarterly report
4:31pm
424B4
6z6iu vzxkx
13 Sep 19
Prospectus supplement with pricing info
5:08pm
S-1/A
me6i6 u27albf
3 Sep 19
IPO registration (amended)
6:12am
S-1
2q2s9 loxrrt
16 Aug 19
IPO registration
5:15pm